Search Results - "Piroska, Imre"
-
1
Treatment of relapsing multiple sclerosis in Hungary - consensus recommendation from the Hungarian neuroimmunology society
Published in Orphanet journal of rare diseases (07-07-2023)“…Multiple sclerosis (MS) may impact quality of life, careers and family plans of the affected individuals. The current treatments with disease modifying…”
Get full text
Journal Article -
2
VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?
Published in Ideggyógyászati szemle (30-03-2014)“…The Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) has been published in 2008 as the successor of the…”
Get full text
Journal Article -
3
Independent validation of Parkinson’s disease Sleep Scale 2nd version (PDSS-2)
Published in Sleep and biological rhythms (2016)“…Sleep problems are one of the most common non-motor symptoms of Parkinson’s disease (PD). The Parkinson’s disease Sleep Scale 2nd version (PDSS-2) was…”
Get full text
Journal Article -
4
VALIDATION OF THE HUNGARIAN UNIFIED DYSKINESIA RATING SCALE
Published in Ideggyógyászati szemle (30-05-2015)“…The Unified Dyskinesia Rating Scale (UDysRS) was published in 2008. It was designed to be simultaneous valid, reliable and sensitive to therapeutic changes…”
Get full text
Journal Article -
5
Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson’s Disease?
Published in Parkinson's disease (01-01-2014)“…Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) has separate items for measuring sleep problems (item 1.7) and daytime…”
Get full text
Journal Article -
6
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
Published in JAMA : the journal of the American Medical Association (15-01-2019)“…IMPORTANCE: Within 2 decades of onset, 80% of untreated patients with relapsing-remitting multiple sclerosis (MS) convert to a phase of irreversible disability…”
Get full text
Journal Article -
7
The relevance of combined testing of cerebrospinal fluid glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 in multiple sclerosis and peripheral neuropathy
Published in Neurological sciences (20-11-2024)“…This study investigates the significance of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCHL-1) in cerebrospinal fluid (CSF)…”
Get full text
Journal Article -
8
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
Published in Neurology (02-02-2021)“…To test the hypothesis that immunotherapy prevents long-term disability in relapsing-remitting multiple sclerosis (MS), we modeled disability outcomes in…”
Get full text
Journal Article -
9
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
Published in JAMA neurology (01-07-2023)“…Autologous hematopoietic stem cell transplant (AHSCT) is available for treatment of highly active multiple sclerosis (MS). To compare the effectiveness of…”
Get more information
Journal Article -
10
Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Published in Brain (London, England : 1878) (01-09-2020)“…In multiple sclerosis, treatment start or switch is prompted by evidence of disease activity. Whilst immunomodulatory therapies reduce disease activity, the…”
Get full text
Journal Article -
11
Do Hungarian multiple sclerosis care units fulfil international criteria?
Published in PloS one (03-03-2022)“…Because of the past 3 decades' extensive research, several disease modifying therapies became available, thus a paradigm change is multiple sclerosis care was…”
Get full text
Journal Article -
12
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS
Published in Neurology (05-09-2017)“…OBJECTIVE:To investigate the effect of disease-modifying treatment on short-term disability outcomes in secondary progressive multiple sclerosis (SPMS)…”
Get full text
Journal Article -
13
Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years
Published in Neurology (25-11-2020)Get full text
Journal Article -
14
Do Hungarian multiple sclerosis care units fulfil international criteria?
Published in PloS one (01-01-2022)“…A patientsBecause of the past 3 decades' extensive research, several disease modifying therapies became available, thus a paradigm change is multiple sclerosis…”
Get full text
Journal Article -
15
Utilization of acute vascular imaging and neurointervention for acute ischaemic stroke patients in 20 Hungarian stroke centers
Published in Ideggyógyászati szemle (30-11-2019)“…Acute mortality rate of stroke in Hungary is significantly higher than in Western Europe, which is likely to be partially attributable to suboptimal treatment…”
Get full text
Journal Article -
16
Az akut vascularis képalkotás és a neurointervenció igénybevétele akut ischaemiás stroke betegeknél Magyarországon
Published in Ideggyógyászati szemle (2019)Get full text
Journal Article